Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/2337
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanchagnula, Ramesh-
dc.contributor.authorSunil Thomas, Narisetty-
dc.date.accessioned2019-11-27T11:00:41Z-
dc.date.available2019-11-27T11:00:41Z-
dc.date.issued1999-09-07-
dc.identifier.urihttp://hdl.handle.net/123456789/2337-
dc.description.abstractWith the synergistic and multiplicative interactions of rational drug design, recombinant biotechnology, combinatorial chemistry and high-throughput screening, millions of compounds are being synthesized by chemists. However, development of these drug candidates has often been impeded, if not terminated, due to biopharmaceutic and:or pharmacokinetic constraints. This has resulted in delays in development time and escalation of cost in the drug research programmes. So, the present emphasis is to reduce development time and cost, which is analogous to added patent life besides the enormous reduction in human suffering. In this compilation the important biopharmaceutic and pharmacokinetic approaches are discussed, which will help in the development of safe and more efficacious drugs with reduced development time and cost. © 2000 Elsevier Science B.V. All rights reserved.en_US
dc.language.isoenen_US
dc.publisherELSEVIERen_US
dc.subjectNew drug developmenten_US
dc.subjectBiopharmaceuticsen_US
dc.titleBiopharmaceutics and pharmacokinetics in drug researchen_US
dc.typeArticleen_US
Appears in Collections:Reference Material

Files in This Item:
File Description SizeFormat 
application in drug research.pdf252.99 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.